HPS Pharmacies wish to give notice that Advanz is experiencing a supply issue for Mytolac® as follows:
Mytolac® Pre-filled Syringe
Lanreotide (as acetate) 90mg
ARTG 371880
To address this issue, Advanz is supplying Mytolac® 90mg, originally manufactured for the German market. The product is presented in the outer carton normally used for the Australian market and contains an Australian product information leaflet. However, the syringe and pouch labels are in German.
As the outer carton will appear the same as the usual product supplied in Australia, the batch number can be used to identify products containing the German inner pouch. The only batch affected is 4400167IR1 (Expiry 01/2026). Subsequent batches will return to the full Australian packaging and labelling.
Outer carton (English labelling)
Inner pouch (German labelling)
Please note: The formulation of the German product is identical to the Australian-registered product. They are also manufactured in the same facility to the same specifications and standards.
Where this product is supplied to patients for self-administration, the patient or carer must be informed of this temporary change in labelling.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Further information provided by Advanz can be accessed here. Should you require additional information regarding this matter, please contact Advanz on (02) 9431 6333 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates